Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 16/02/2023, 18:12
© Reuters.  Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga - Gainers

  • TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
  • NexImmune, Inc. (NASDAQ: NEXI) rose 62% to $0.6640 after the company announced data showing AIM ACT T cells enhance the response to bispecific T cell engager therapy at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.
  • Ambrx Biopharma Inc. (NASDAQ: AMAM) climbed 52% to $2.7510 after the company reported initial data from its ongoing Phase 1 Apex-01 trial of ARX517 in prostate cancer patients, demonstrating prostate-specific antigen decrease of over 50% from baseline in 3 of 3 patients receiving 2.0mg/kg dose.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) gained 39.2% to $0.2301. Sorrento Therapeutics recently said its Scintilla Pharmaceuticals unit commenced voluntary proceedings under Chapter 11 of US bankruptcy code.
  • Inozyme Pharma, Inc. (NASDAQ: INZY) gained 35.1% to $2.9998 after the company reported topline data from its onging Phase 1/2 trials of INZ-701.
  • Community Health Systems, Inc. (NYSE: CYH) shares climbed 34.5% to $6.83 after the company reported better-than-expected Q4 earnings.
  • Intuitive Machines, Inc. (NASDAQ: LUNR) gained 32.6% to $16.90.
  • Boxed, Inc. (NYSE: BOXD) rose 24.6% to $0.5513 after dropping around 8% on Wednesday.
  • Talaris Therapeutics, Inc. (NASDAQ: TALS) gained 23.4% to $1.95. Talaris Therapeutics announced plans to discontinue its FREEDOM-1 and FREEDOM-2 trials evaluating FCR001's ability to induce durable tolerance in living donor
  • kidney transplant recipients, primarily attributable to the pace of enrollment and the associated timeline.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) surged 22.3% to $0.0870.
  • Service Properties Trust (NYSE: SVC) jumped 21.7% to $10.49. Service Properties Trust agreed to amended lease terms upon completion of BP’s acquisition of TravelCenters of America Inc.
  • Ribbon Communications Inc. (NASDAQ: RBBN) gained 19.7% to $4.55 after the company reported better-than-expected Q4 sales.
  • Freedom Holding Corp. (NASDAQ: FRHC) jumped 18.8% to $75.73 after the company announced it agreed to acquire Maxim Group for a total consideration of $400 million.
  • Materion Corporation (NYSE: MTRN) gained 18.4% to $104.98 following Q4 results.
  • Twilio Inc. (NYSE: TWLO) rose 17.6% to $77.69 after the company reported better-than-expected Q4 sales and announced a $1 billion buyback program.
  • Biotricity, Inc. (NASDAQ: BTCY) climbed 17.5% to $0.7903. On Wednesday, the company posted upbeat quarterly results.
  • Roku, Inc. (NASDAQ: ROKU) climbed 15.8% to $73.49 after the company reported better-than-expected Q4 results. The company added 4.6 million net new native accounts in the quarter.
  • West Pharmaceutical Services, Inc. (NYSE: WST) gained 15.8% to $323.52 after the company reported better-than-expected Q4 adjusted EPS and sales results. Additionally, the company issued FY23 revenue guidance above analyst estimates.
  • Natera, Inc. (NASDAQ: NTRA) gained 15.8% to $49.02.
  • Pegasystems Inc. (NASDAQ: PEGA) jumped 14.7% to $48.99 after the company reported better-than-expected Q4 results and issued FY23 revenue guidance above estimates.
  • Fastly, Inc. (NYSE: FSLY) jumped 13.7% to $15.77 following Q4 results.
  • Seagen Inc. (NASDAQ: SGEN) rose 13.7% to $161.54 after the company reported better-than-expected Q4 results.
  • IBEX Limited (NASDAQ: IBEX) gained 13.4% to $29.74 following strong quarterly earnings.
  • Axcella Health Inc. (NASDAQ: AXLA) shares rose 12.6% to $0.6796 after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S. for AXA1125.
  • Aspen Aerogels, Inc. (NYSE: ASPN) gained 11.6% to $12.84 following strong quarterly results.
  • PBF Energy Inc. (NYSE: PBF) surged 10.8% to $46.34 after the company reported mixed Q4 financial results.
  • KBR, Inc. (NYSE: KBR) jumped 10.8% to $57.36 following upbeat quarterly results.
  • The NFT Gaming Company, Inc. (NASDAQ: NFTG) gained 10.1% to $4.46. The NFT Gaming Company priced its $7 million initial public offering of 1,686,747 shares of common stock at a price of $4.15 per share.
  • Cipher Mining Inc. (NASDAQ: CIFR) rose 7.1% to $1.96 after jumping over 20% on Wednesday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Atlis Motor Vehicles, Inc. (NASDAQ: AMV) shares fell 36.4% to $1.08 after the company reported pricing of $13.0 million public offering.
  • Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) dropped 22.7% to $1.26.
  • RingCentral, Inc. (NYSE: RNG) fell 22.6% to $37.45 after the company reported worse-than-expected Q4 revenue and issued weak revenue guidance for the first quarter.
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) dipped 22.4% to $0.52 after the company announced a $1.5 million registered direct offering of common stock priced at-the-market under Nasdaq rules.
  • Kaleyra, Inc. (NYSE: KLR) fell 21% to $1.0193. Kaleyra posted a Q4 loss of $0.10 per share.
  • Toast, Inc. (NYSE: TOST) shares dropped 19% to $21.04 after the company reported worse-than-expected Q4 EPS earnings.
  • Coursera, Inc. (NYSE: COUR) fell 16.9% to $13.01. Coursera recently reported Q4 earnings results.
  • Kelly Services, Inc. (NASDAQ: KELYA) dropped 16.3% to $15.36 after the company reported worse-than-expected Q4 adjusted EPS and sales results.
  • Shopify Inc. (NYSE: SHOP) fell 16.1% to $44.81 despite better-than-expected Q4 results. The company also guided revenue growth in the high-teen percentages for Q1.
  • Titan Medical Inc. (NASDAQ: TMDI) shares declined 15.7% to $0.2066.
  • Organon & Co. (NYSE: OGN) fell 15.3% to $24.78 following weak quarterly results.
  • QuantumScape Corporation (NYSE: QS) dipped 15.4% to $10.01 after the company reported worse-than-expected Q4 EPS.
  • Brera Holdings PLC (NASDAQ: BREA) dropped 15.3% to $2.44.
  • QuantumScape Corporation (NASDAQ: QS) fell 14.7% to $10.10 after the company reported worse-than-expected Q4 EPS.
  • SolarWinds Corporation (NYSE: SWI) dipped 14.2% to $8.91.
  • Amplitude, Inc. (NASDAQ: AMPL) dropped 14% to $14.40 after the company issued weak Q1 guidance.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) dropped 13.6% to $1.53. Hillstream BioPharma recently regained compliance with Nasdaq listing minimum bid price rule.
  • Ur-Energy Inc. (NYSE: URG) fell 13.4% to $1.1350 after the company reported pricing of public offering of common shares and warrants.
  • Kelly Services, Inc. (NASDAQ: KELYB) declined 13.2% to $15.62 after the company reported worse-than-expected Q4 adjusted EPS and sales results.
  • The Boston Beer Company, Inc. (NYSE: SAM) fell 12.9% to $342.11 after the company reported worse-than-expected Q4 EPS and issued soft guidance. The company said margins came in below expectations due to production mix and supply chain inefficiencies.
  • Pharming Group N.V. (NASDAQ: PHAR) dropped 12.8% to $11.52. Pharming issued an update on European Medicines Agency regulatory review of Leniolisib for APDS in Europe.
  • Movella Holdings Inc. (NASDAQ: MVLA) dropped 12.8% to $3.55. Movella announced OBSKUR early access livestreaming software.
  • Dun & Bradstreet Holdings, Inc. (NYSE: DNB) fell 11.1% to $12.69 following weak quarterly results.
  • Scilex Holding Company (NASDAQ: SCLX) fell 9.6% to $7.47.
  • Tripadvisor, Inc. (NASDAQ: TRIP) dropped 8.8% to $22.97. Bernstein downgraded TripAdvisor from Outperform to Market Perform and lowered the price target from $28 to $26. TripAdvisor recently reported better-than-expected Q4 EPS and sales results.
  • 2U, Inc. (NASDAQ: TWOU) fell 8.5% to $10.18.
  • Tronox Holdings plc (NYSE: TROX) dipped 7.4% to $15.01 after the company reported worse-than-expected Q4 results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.